Search

Author/Creator Beijnen, J.H.

1. A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO‐101 in Patients With Advanced Solid Tumors. (18th June 2013)

Authors:
Stuurman, F.E.; Lolkema, M.P.; Huitema, A.D.R.; Soetekouw, P.M.M.B.; Rosing, H.; Rolfe, L.; Kaur, P.; Beijnen, J.H.; van Tinteren, H.; Voest, E.E.; Schellens, J.H.M.
Journal:
Journal of clinical pharmacology
Issue:
Volume 53:Number 8(2013:Aug.)
Page Start:
878
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial. (September 2022)

Authors:
Rohaan, M.W.; Gomez-Eerland, R.; van den Berg, J.H.; Geukes Foppen, M.H.; van Zon, M.; Raud, B.; Jedema, I.; Scheij, S.; de Boer, R.; Bakker, N.A.M.; van den Broek, D.; Pronk, L.M.; Grijpink-Ongering, L.G.; Sari, A.; Kessels, R.; van den Haak, M.; Mallo, H.A.; Karger, M.; van de Wiel, B.A.; Zuur,...
Journal:
Immuno-oncology technology
Issue:
Volume 15(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗